Physician profile
Easter Tjandra
NPI 1730161506
$5,230.94
in general payments reported to CMS, 2019-2025
18 companies · $797 in 2025
The $797 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $746 · 2021: $352 · 2022: $1,073 · 2023: $410 · 2024: $978 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,003 · Entertainment: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,002.67 |
| Entertainment | $181.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,378.98 | 2022-2025 | Infuse |
| Alcon Vision LLC | $888.66 | 2021-2024 | Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $523.39 | 2019-2021 | |
| Optos, INC. | $432.47 | 2020-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $420.59 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Biofinity Contact Lens |
| Johnson & Johnson Vision Care, INC. | $205.12 | 2019-2021 | |
| Genzyme Corporation | $193.33 | 2019-2022 | |
| Sight Sciences, INC. | $181.76 | 2019-2020 | |
| Glaukos Corporation | $137.52 | 2024 | Radius |
| Aerie Pharmaceuticals, INC. | $127.47 | 2019 | |
| Maculogix, INC. | $125.65 | 2019 | |
| Sun Pharmaceutical Industries INC. | $121.82 | 2025 | |
| Dompe US, INC. | $121.77 | 2025 | Oxervate |
| Biotissue Holdings INC. | $120.08 | 2024 | |
| Novartis Pharmaceuticals Corporation | $118.77 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $96.92 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Easter Tjandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.